Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
N4 Pharma Plc logo — Developing Nuvec®: A breakthrough technology for mRNA / pDNA...

N4 Pharma Plc

Developing Nuvec®: A breakthrough technology for mRNA / pDNA delivery for vaccines and cancer treatments.

Founded 2014 United Kingdom United Kingdom 4 employees Grant Total: $119.00K Health and Wellness, Pharmaceutical

General Information

Company Name N4 Pharma Plc
Founded Year 2014
Location United Kingdom United Kingdom +1
Employees 4
Industries Health and Wellness, Pharmaceutical
Funding Stage Grant
Social

Get notified when N4 Pharma Plc moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About N4 Pharma Plc

N4 Pharma Plc is a drug reformulation company focused on developing and out licensing new versions of existing and novel high value drugs with an unmet commercial or medical need. The company's commercial strategy involves advancing a pipeline of products through clinical proof of concept and then partnering to take the products through the relevant regulatory pathway studies to regulatory approval. Recently, N4 Pharma acquired the rights to a range of patents from OPAL IP to allow it to reformulate a wide range of existing drugs using a range of techniques. Additionally, the company has two proprietary platform delivery system technologies that enable it to improve a vaccine's performance. The first system enhances cellular uptake of sub unit vaccines, while the second improves transfection efficiency of cancer vaccines and therapeutics. Founded in 2014 and headquartered in the United Kingdom, N4 Pharma's first product in development is a 'reformulated' version of Sildenafil (Viagra) aimed at improving the onset of action and maintaining an effective dose of the drug during the therapeutic window to make it last longer. In terms of investment, N4 Pharma's last investment was a £119.00K grant investment received on January 5, 2017, with Innovate UK as the investor.

Taxonomy: drug reformulation, mRNA delivery, pDNA delivery, vaccine technology, cancer treatment, patent acquisition, proprietary platform delivery system, Sildenafil reformulation, clinical proof of concept, regulatory pathway studies, pharmaceutical technology, medical innovation, drug development, licensing partnerships

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Grant •••••• 1
Investor
05 Jan 2017

N4 Pharma Plc Alternatives & Competitors

N4 Pharma Plc vs
Therakind Limited
Therakind Limited United Kingdom

Enhancing access to safe and effective specialized medicines for children and underserved patient gr...

Series Unknown
11 employees
Health Care, Pharmaceutical
N4 Pharma Plc vs
Bostal Drug Delivery
Bostal Drug Delivery

Innovative drug delivery solutions enhancing the development and improvement of pharmaceuticals sinc...

Series B
Biotechnology, Health Care
N4 Pharma Plc vs
Orion Therapeutics, Inc.
Orion Therapeutics, Inc. United States

Platform technology providing targeted delivery of RNA aimed at curing and preventing previously und...

7 employees
Biotechnology, Health Care

FAQ About N4 Pharma Plc

Developing Nuvec®: A breakthrough technology for mRNA / pDNA delivery for vaccines and cancer treatments.
N4 Pharma Plc was founded in 2014.
N4 Pharma Plc is headquartered in United Kingdom.
N4 Pharma Plc operates in the following industries: Health and Wellness, Pharmaceutical.
N4 Pharma Plc has approximately 4 employees.
N4 Pharma Plc has completed 1 funding round, raising a total of $119.00K. The latest funding stage is Grant.
Top alternatives and competitors to N4 Pharma Plc include Therakind Limited, Bostal Drug Delivery, Orion Therapeutics, Inc., Zosano Pharma, TheraJect, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
N4 Pharma Plc and Therakind Limited are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors N4 Pharma Plc and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes